Qualification of Drivers; Exemption Applications; Epilepsy and Seizure Disorders, 79397-79399 [2015-31978]
Download as PDF
Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices
Exchange does not believe that the
proposed rule change will impose any
burden on competition not necessary or
appropriate in furtherance of the
purposes of the Act.
C. Self-Regulatory Organization’s
Statement on Comments on the
Proposed Rule Change Received From
Members, Participants, or Others
No written comments were either
solicited or received.
III. Date of Effectiveness of the
Proposed Rule Change and Timing for
Commission Action
Because the foregoing proposed rule
change does not: (i) Significantly affect
the protection of investors or the public
interest; (ii) impose any significant
burden on competition; and (iii) become
operative for 30 days from the date on
which it was filed, or such shorter time
as the Commission may designate, it has
become effective pursuant to section
19(b)(3)(A)(iii) of the Act 7 and
subparagraph (f)(6) of Rule 19b–4
thereunder.8
At any time within 60 days of the
filing of the proposed rule change, the
Commission summarily may
temporarily suspend such rule change if
it appears to the Commission that such
action is: (i) Necessary or appropriate in
the public interest; (ii) for the protection
of investors; or (iii) otherwise in
furtherance of the purposes of the Act.
If the Commission takes such action, the
Commission shall institute proceedings
to determine whether the proposed rule
should be approved or disapproved.
IV. Solicitation of Comments
Interested persons are invited to
submit written data, views, and
arguments concerning the foregoing,
including whether the proposed rule
change is consistent with the Act.
Comments may be submitted by any of
the following methods:
Electronic Comments
• Use the Commission’s Internet
comment form (https://www.sec.gov/
rules/sro.shtml); or
• Send an email to rule-comments@
sec.gov. Please include File Number SR–
Phlx–2015–105 on the subject line.
mstockstill on DSK4VPTVN1PROD with NOTICES
Paper Comments
• Send paper comments in triplicate
to Secretary, Securities and Exchange
Commission, 100 F Street NE.,
Washington, DC 20549–1090.
All submissions should refer to File
Number SR–Phlx–2015–105. This file
7 15
8 17
U.S.C. 78s(b)(3)(A)(iii).
CFR 240.19b–4(f)(6).
VerDate Sep<11>2014
17:38 Dec 18, 2015
number should be included on the
subject line if email is used. To help the
Commission process and review your
comments more efficiently, please use
only one method. The Commission will
post all comments on the Commission’s
Internet Web site (https://www.sec.gov/
rules/sro.shtml). Copies of the
submission, all subsequent
amendments, all written statements
with respect to the proposed rule
change that are filed with the
Commission, and all written
communications relating to the
proposed rule change between the
Commission and any person, other than
those that may be withheld from the
public in accordance with the
provisions of 5 U.S.C. 552, will be
available for Web site viewing and
printing in the Commission’s Public
Reference Room, 100 F Street NE.,
Washington, DC 20549 on official
business days between the hours of
10:00 a.m. and 3:00 p.m. Copies of such
filing also will be available for
inspection and copying at the principal
offices of the Exchange. All comments
received will be posted without change;
the Commission does not edit personal
identifying information from
submissions. You should submit only
information that you wish to make
available publicly. All submissions
should refer to File Number SR–Phlx–
2015–105, and should be submitted on
or before January 11, 2016.
For the Commission, by the Division of
Trading and Markets, pursuant to delegated
authority.9
Robert W. Errett,
Deputy Secretary.
[FR Doc. 2015–31925 Filed 12–18–15; 8:45 am]
BILLING CODE 8011–01–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
[Docket No. FMCSA–2015–0320]
Qualification of Drivers; Exemption
Applications; Epilepsy and Seizure
Disorders
Federal Motor Carrier Safety
Administration (FMCSA), DOT.
ACTION: Notice of applications for
exemptions; request for comments.
AGENCY:
FMCSA announces receipt of
applications from 17 individuals for an
exemption from the prohibition against
persons with a clinical diagnosis of
epilepsy or any other condition that is
SUMMARY:
9 17
Jkt 238001
PO 00000
CFR 200.30–3(a)(12).
Frm 00096
Fmt 4703
Sfmt 4703
79397
likely to cause a loss of consciousness
or any loss of ability to operate a
commercial motor vehicle (CMV) in
interstate commerce. The regulation and
the associated advisory criteria
published in the Code of Federal
Regulations as the ‘‘Instructions for
Performing and Recording Physical
Examinations’’ have resulted in
numerous drivers being prohibited from
operating CMVs in interstate commerce
based on the fact that they have had one
or more seizures and are taking antiseizure medication, rather than an
individual analysis of their
circumstances by a qualified medical
examiner. If granted, the exemptions
would enable these individuals who
have had one or more seizures and are
taking anti-seizure medication to
operate CMVs for up to 2 years in
interstate commerce.
DATES: Comments must be received on
or before January 20, 2016.
ADDRESSES: You may submit comments
bearing the Federal Docket Management
System (FDMS) Docket ID FMCSA–
2015–0320 using any of the following
methods:
• Federal eRulemaking Portal: Go to
www.regulations.gov. Follow the on-line
instructions for submitting comments.
• Mail: Docket Management Facility;
U.S. Department of Transportation, 1200
New Jersey Avenue SE., West Building
Ground Floor, Room W12–140,
Washington, DC 20590–0001.
• Hand Delivery or Courier: West
Building Ground Floor, Room W12–140,
1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5
p.m., Monday through Friday, except
Federal Holidays.
• Fax: 1–202–493–2251.
Each submission must include the
Agency name and the docket ID for this
Notice. Note that DOT posts all
comments received without change to
www.regulations.gov, including any
personal information included in a
comment. Please see the Privacy Act
heading below.
Docket: For access to the docket to
read background documents or
comments, go to www.regulations.gov,
at any time or Room W12–140 on the
ground level of the West Building, 1200
New Jersey Avenue SE., Washington,
DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
The FDMS is available 24 hours each
day, 365 days each year. If you want
acknowledgment that we received your
comments, please include a selfaddressed, stamped envelope or
postcard or print the acknowledgement
page that appears after submitting
comments on-line.
E:\FR\FM\21DEN1.SGM
21DEN1
79398
Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices
Privacy Act: In accordance with 5
U.S.C. 553(c), DOT solicits comments
from the public to better inform its
rulemaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to www.regulations.gov, as
described in the system records notice
(DOT/ALL–14 FDMS), which can be
reviewed at www.dot.gov/privacy.
FOR FURTHER INFORMATION CONTACT:
Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001, or
via email at fmcsamedical@dot.gov, or
by letter to FMCSA, Room W64–113,
Department of Transportation, 1200
New Jersey Avenue SE., Washington,
DC 20590–0001. Office hours are from
8:30 a.m. to 5 p.m., Monday through
Friday, except Federal holidays.
SUPPLEMENTARY INFORMATION:
mstockstill on DSK4VPTVN1PROD with NOTICES
Background
Under 49 U.S.C. 31315 and 31136(e),
FMCSA may grant an exemption for up
to a 2-year period if it finds ‘‘such
exemption would likely achieve a level
of safety that is equivalent to or greater
than the level that would be achieved
absent such exemption.’’ The statutes
allow the Agency to renew exemptions
at the end of the 2-year period. The 17
individuals listed in this notice have
requested an exemption from the
epilepsy prohibition in 49 CFR
391.41(b)(8), which applies to drivers
who operate CMVs as defined in 49 CFR
390.5, in interstate commerce. Section
391.41(b)(8) states that a person is
physically qualified to drive a CMV if
that person has no established medical
history or clinical diagnosis of epilepsy
or any other condition which is likely
to cause the loss of consciousness or any
loss of ability to control a CMV.
FMCSA provides medical advisory
criteria for use by medical examiners in
determining whether drivers with
certain medical conditions should be
certified to operate CMVs in intrastate
commerce. The advisory criteria
indicate that if an individual has had a
sudden episode of a non-epileptic
seizure or loss of consciousness of
unknown cause that did not require
anti-seizure medication, the decision
whether that person’s condition is likely
to cause the loss of consciousness or
loss of ability to control a CMV should
be made on an individual basis by the
medical examiner in consultation with
the treating physician. Before
certification is considered, it is
suggested that a 6-month waiting period
elapse from the time of the episode.
Following the waiting period, it is
suggested that the individual have a
complete neurological examination. If
VerDate Sep<11>2014
17:38 Dec 18, 2015
Jkt 238001
the results of the examination are
negative and anti-seizure medication is
not required, then the driver may be
qualified.
In those individual cases where a
driver had a seizure or an episode of
loss of consciousness that resulted from
a known medical condition (e.g., drug
reaction, high temperature, acute
infectious disease, dehydration, or acute
metabolic disturbance), certification
should be deferred until the driver has
recovered fully from that condition, has
no existing residual complications, and
is not taking anti-seizure medication.
Drivers who have a history of epilepsy/
seizures, off anti-seizure medication and
seizure-free for 10 years, may be
qualified to operate a CMV in interstate
commerce. Interstate drivers with a
history of a single unprovoked seizure
may be qualified to drive a CMV in
interstate commerce if seizure-free and
off anti-seizure medication for a 5-year
period or more.
Submitting Comments
You may submit your comments and
material online or by fax, mail, or hand
delivery, but please use only one of
these means. FMCSA recommends that
you include your name and a mailing
address, an email address, or a phone
number in the body of your document
so that FMCSA can contact you if there
are questions regarding your
submission. To submit your comment
online, go to https://www.regulations.gov
and in the search box insert the docket
number ‘‘FMCSA–2015–0320’’ and click
the search button. When the new screen
appears, click on the blue ‘‘Comment
Now!’’ button on the right hand side of
the page. On the new page, enter
information required including the
specific section of this document to
which each comment applies, and
provide a reason for each suggestion or
recommendation. If you submit your
comments by mail or hand delivery,
submit them in an unbound format, no
larger than 81⁄2 by 11 inches, suitable for
copying and electronic filing. If you
submit comments by mail and would
like to know that they reached the
facility, please enclose a stamped, selfaddressed postcard or envelope. We will
consider all comments and material
received during the comment period
and may change this proposed rule
based on your comments. FMCSA may
issue a final rule at any time after the
close of the comment period.
Viewing Comments and Documents
To view comments, as well as any
documents mentioned in this preamble,
To submit your comment online, go to
https://www.regulations.gov and in the
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
search box insert the docket number
‘‘FMCSA–2015–0320’’ and click
‘‘Search.’’ Next, click ‘‘Open Docket
Folder’’ and you will find all documents
and comments related to the proposed
rulemaking.
Summary of Applications
James E. Allen
Mr. Allen is a 48 year-old driver in
Maine. He has a history of a seizure
disorder and has remained seizure free
since 1992. He takes anti-seizure
medication with the dosage and
frequency remaining the same since
2003. His physician states that he is
supportive of Mr. Allen receiving an
exemption.
Richard A. Bailey
Mr. Bailey is a 65 year-old class A
CDL holder in Iowa. He has a history of
a seizure disorder and has remained
seizure free since 2009. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Bailey receiving an
exemption.
Thomas A. DeAngelo
Mr. DeAngelo is a 43 year-old class A
CDL holder in Illinois. He has a history
of a seizure disorder and has remained
seizure free since 1990. He takes antiseizure medication with the dosage and
frequency remaining the same since
1998. His physician states that he is
supportive of Mr. DeAngelo receiving an
exemption.
Nathan Dermer
Mr. Dermer is a 40 year-old driver in
Alaska. He has a history of a benign
brain tumor removal in 1991 and a
single seizure in 1994. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Dermer receiving an
exemption.
Daniel Lloyd Halstead
Mr. Halstead is a 63 year-old class A
CDL holder in Nevada. He has a history
of a seizure disorder and has remained
seizure free since 1973. He takes antiseizure medication with the dosage and
frequency remaining the same since
2005. His physician states that he is
supportive of Mr. Halstead receiving an
exemption.
Kevin Mathis
Mr. Mathis is a 29 year-old driver in
New Jersey. He has a history of juvenile
myoclonic epilepsy and has remained
seizure free since 2003. He takes antiseizure medication with the dosage and
E:\FR\FM\21DEN1.SGM
21DEN1
Federal Register / Vol. 80, No. 244 / Monday, December 21, 2015 / Notices
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Mathis receiving an
exemption.
Toriano T. Mitchell
Mr. Mitchell is a 32 year-old class B
CDL holder in Ohio. He has a history of
a seizure disorder and has remained
seizure free since 2003. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Mitchell receiving an
exemption.
Thomas A. Mitman
Mr. Mitman is a 58 year-old class A
CDL holder in New York. He has a
history of a seizure disorder and has
remained seizure free since 1996. He
takes anti-seizure medication with the
dosage and frequency remaining the
same since that time. His physician
states that he is supportive of Mr.
Mitman receiving an exemption.
Mr. Murphy is a 39 year-old driver in
Massachusetts. He has a history of a
single seizure and tumor removal in
2011. He was previously on anti-seizure
medication but discontinued it 2015.
His physician states that he is
supportive of Mr. Murphy receiving an
exemption.
Jason Christopher Nikolas
Mr. Nikolas is a 42 year-old driver in
Virginia. He has a history of epilepsy
and has remained seizure free since
2012. He takes anti-seizure medication
with the dosage and frequency
remaining the same since that time. His
physician states that he is supportive of
Mr. Nikolas receiving an exemption.
Curtis Joseph Palubicki
mstockstill on DSK4VPTVN1PROD with NOTICES
Franklin Prettyman
Mr. Prettyman is a 77 year-old driver
in Maryland. He has a history of a
seizure disorder and has remained
seizure free since 2012. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Prettyman receiving
an exemption.
Jkt 238001
Dated: December 9, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015–31978 Filed 12–18–15; 8:45 am]
BILLING CODE 4910–EX–P
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety
Administration
Isaac E. Rogers
[FMCSA Docket No. FMCSA–2015–0066]
Mr. Rogers is a 29 year-old class A
CDL holder in Illinois. He has a history
of a seizure disorder and has remained
seizure free since 2009. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Rogers receiving an
exemption.
Mr. Schaefor is a 34 year-old driver in
Maine. He has a history of a seizure
disorder and has remained seizure free
since 2003. He takes anti-seizure
medication with the dosage and
frequency remaining the same since
2008. His physician states that he is
supportive of Mr. Schaefor receiving an
exemption.
Kenneth P. Schmitt
Mr. Schmitt is a 38 year-old driver in
South Dakota. He has a history of a
seizure disorder and his last seizure
date is not documented. He takes antiseizure medication with the dosage and
frequency remaining the same and his
physician notes that Mr. Schmitt admits
to occasional anti-seizure medication
noncompliance. His physician states
that he is supportive of Mr. Schmittt
receiving an exemption.
Alfonso Valdivieso
Mr. Palubicki is a 29 year-old driver
in Minnesota. He has a history of
epilepsy and has remained seizure free
since September 2008. He takes antiseizure medication with the dosage and
frequency remaining the same since that
time. His physician states that he is
supportive of Mr. Palubicki receiving an
exemption.
17:38 Dec 18, 2015
Mr. Riemenschneider is a 35 year-old
driver in Texas. He has a history of a
single seizure in 2011 related to a brain
tumor. He takes anti-seizure medication
with the dosage and frequency
remaining the same since that time. His
physician states that he is supportive of
Mr. Riemenschneider receiving an
exemption.
Tyler W. Schaefor
James P. Murphy
VerDate Sep<11>2014
Chad Riemenschneider
79399
Mr. Valdivieso is a 52 year-old class
A CDL holder in New York. He has a
history of a seizure disorder and has
remained seizure free since 2011. He
takes anti-seizure medication with the
dosage and frequency remaining the
same since that time. His physician
states that he is supportive of Mr.
Valdivieso receiving an exemption.
Request for Comments
In accordance with 49 U.S.C. 31315
and 31136(e), FMCSA requests public
comment from all interested persons on
the exemption applications described in
this notice. We will consider all
comments received before the close of
business on the closing date indicated
earlier in the notice.
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
Qualification of Drivers; Exemption
Applications; Diabetes Mellitus
Federal Motor Carrier Safety
Administration (FMCSA), DOT
ACTION: Notice of final disposition.
AGENCY:
FMCSA confirms its decision
to exempt 54 individuals from its rule
prohibiting persons with insulin-treated
diabetes mellitus (ITDM) from operating
commercial motor vehicles (CMVs) in
interstate commerce. The exemptions
enable these individuals to operate
CMVs in interstate commerce.
DATES: The exemptions were effective
on September 17, 2015. The exemptions
expire on September 17, 2017.
FOR FURTHER INFORMATION CONTACT:
Christine A. Hydock, Chief, Medical
Programs Division, (202) 366–4001,
fmcsamedical@dot.gov, FMCSA,
Department of Transportation, 1200
New Jersey Avenue SE., Room W64–
113, Washington, DC 20590–0001.
Office hours are from 8:30 a.m. to 5 p.m.
e.t., Monday through Friday, except
Federal holidays.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Electronic Access
You may see all the comments online
through the Federal Document
Management System (FDMS) at: https://
www.regulations.gov.
Docket: For access to the docket to
read background documents or
comments, go to https://
www.regulations.gov and/or Room
W12–140 on the ground level of the
West Building, 1200 New Jersey Avenue
SE., Washington, DC, between 9 a.m.
and 5 p.m., Monday through Friday,
except Federal holidays.
Privacy Act: In accordance with 5
U.S.C. 553(c), DOT solicits comments
from the public to better inform its
rulemaking process. DOT posts these
comments, without edit, including any
personal information the commenter
provides, to www.regulations.gov, as
described in the system of records
notice (DOT/ALL–14 FDMS), which can
be reviewed at www.dot.gov/privacy.
E:\FR\FM\21DEN1.SGM
21DEN1
Agencies
[Federal Register Volume 80, Number 244 (Monday, December 21, 2015)]
[Notices]
[Pages 79397-79399]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-31978]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF TRANSPORTATION
Federal Motor Carrier Safety Administration
[Docket No. FMCSA-2015-0320]
Qualification of Drivers; Exemption Applications; Epilepsy and
Seizure Disorders
AGENCY: Federal Motor Carrier Safety Administration (FMCSA), DOT.
ACTION: Notice of applications for exemptions; request for comments.
-----------------------------------------------------------------------
SUMMARY: FMCSA announces receipt of applications from 17 individuals
for an exemption from the prohibition against persons with a clinical
diagnosis of epilepsy or any other condition that is likely to cause a
loss of consciousness or any loss of ability to operate a commercial
motor vehicle (CMV) in interstate commerce. The regulation and the
associated advisory criteria published in the Code of Federal
Regulations as the ``Instructions for Performing and Recording Physical
Examinations'' have resulted in numerous drivers being prohibited from
operating CMVs in interstate commerce based on the fact that they have
had one or more seizures and are taking anti-seizure medication, rather
than an individual analysis of their circumstances by a qualified
medical examiner. If granted, the exemptions would enable these
individuals who have had one or more seizures and are taking anti-
seizure medication to operate CMVs for up to 2 years in interstate
commerce.
DATES: Comments must be received on or before January 20, 2016.
ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket ID FMCSA-2015-0320 using any of the
following methods:
Federal eRulemaking Portal: Go to www.regulations.gov.
Follow the on-line instructions for submitting comments.
Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590-0001.
Hand Delivery or Courier: West Building Ground Floor, Room
W12-140, 1200 New Jersey Avenue SE., Washington, DC, between 9 a.m. and
5 p.m., Monday through Friday, except Federal Holidays.
Fax: 1-202-493-2251.
Each submission must include the Agency name and the docket ID for
this Notice. Note that DOT posts all comments received without change
to www.regulations.gov, including any personal information included in
a comment. Please see the Privacy Act heading below.
Docket: For access to the docket to read background documents or
comments, go to www.regulations.gov, at any time or Room W12-140 on the
ground level of the West Building, 1200 New Jersey Avenue SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The FDMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
comments on-line.
[[Page 79398]]
Privacy Act: In accordance with 5 U.S.C. 553(c), DOT solicits
comments from the public to better inform its rulemaking process. DOT
posts these comments, without edit, including any personal information
the commenter provides, to www.regulations.gov, as described in the
system records notice (DOT/ALL-14 FDMS), which can be reviewed at
www.dot.gov/privacy.
FOR FURTHER INFORMATION CONTACT: Christine A. Hydock, Chief, Medical
Programs Division, (202) 366-4001, or via email at
fmcsamedical@dot.gov, or by letter to FMCSA, Room W64-113, Department
of Transportation, 1200 New Jersey Avenue SE., Washington, DC 20590-
0001. Office hours are from 8:30 a.m. to 5 p.m., Monday through Friday,
except Federal holidays.
SUPPLEMENTARY INFORMATION:
Background
Under 49 U.S.C. 31315 and 31136(e), FMCSA may grant an exemption
for up to a 2-year period if it finds ``such exemption would likely
achieve a level of safety that is equivalent to or greater than the
level that would be achieved absent such exemption.'' The statutes
allow the Agency to renew exemptions at the end of the 2-year period.
The 17 individuals listed in this notice have requested an exemption
from the epilepsy prohibition in 49 CFR 391.41(b)(8), which applies to
drivers who operate CMVs as defined in 49 CFR 390.5, in interstate
commerce. Section 391.41(b)(8) states that a person is physically
qualified to drive a CMV if that person has no established medical
history or clinical diagnosis of epilepsy or any other condition which
is likely to cause the loss of consciousness or any loss of ability to
control a CMV.
FMCSA provides medical advisory criteria for use by medical
examiners in determining whether drivers with certain medical
conditions should be certified to operate CMVs in intrastate commerce.
The advisory criteria indicate that if an individual has had a sudden
episode of a non-epileptic seizure or loss of consciousness of unknown
cause that did not require anti-seizure medication, the decision
whether that person's condition is likely to cause the loss of
consciousness or loss of ability to control a CMV should be made on an
individual basis by the medical examiner in consultation with the
treating physician. Before certification is considered, it is suggested
that a 6-month waiting period elapse from the time of the episode.
Following the waiting period, it is suggested that the individual have
a complete neurological examination. If the results of the examination
are negative and anti-seizure medication is not required, then the
driver may be qualified.
In those individual cases where a driver had a seizure or an
episode of loss of consciousness that resulted from a known medical
condition (e.g., drug reaction, high temperature, acute infectious
disease, dehydration, or acute metabolic disturbance), certification
should be deferred until the driver has recovered fully from that
condition, has no existing residual complications, and is not taking
anti-seizure medication. Drivers who have a history of epilepsy/
seizures, off anti-seizure medication and seizure-free for 10 years,
may be qualified to operate a CMV in interstate commerce. Interstate
drivers with a history of a single unprovoked seizure may be qualified
to drive a CMV in interstate commerce if seizure-free and off anti-
seizure medication for a 5-year period or more.
Submitting Comments
You may submit your comments and material online or by fax, mail,
or hand delivery, but please use only one of these means. FMCSA
recommends that you include your name and a mailing address, an email
address, or a phone number in the body of your document so that FMCSA
can contact you if there are questions regarding your submission. To
submit your comment online, go to https://www.regulations.gov and in the
search box insert the docket number ``FMCSA-2015-0320'' and click the
search button. When the new screen appears, click on the blue ``Comment
Now!'' button on the right hand side of the page. On the new page,
enter information required including the specific section of this
document to which each comment applies, and provide a reason for each
suggestion or recommendation. If you submit your comments by mail or
hand delivery, submit them in an unbound format, no larger than 8\1/2\
by 11 inches, suitable for copying and electronic filing. If you submit
comments by mail and would like to know that they reached the facility,
please enclose a stamped, self-addressed postcard or envelope. We will
consider all comments and material received during the comment period
and may change this proposed rule based on your comments. FMCSA may
issue a final rule at any time after the close of the comment period.
Viewing Comments and Documents
To view comments, as well as any documents mentioned in this
preamble, To submit your comment online, go to https://www.regulations.gov and in the search box insert the docket number
``FMCSA-2015-0320'' and click ``Search.'' Next, click ``Open Docket
Folder'' and you will find all documents and comments related to the
proposed rulemaking.
Summary of Applications
James E. Allen
Mr. Allen is a 48 year-old driver in Maine. He has a history of a
seizure disorder and has remained seizure free since 1992. He takes
anti-seizure medication with the dosage and frequency remaining the
same since 2003. His physician states that he is supportive of Mr.
Allen receiving an exemption.
Richard A. Bailey
Mr. Bailey is a 65 year-old class A CDL holder in Iowa. He has a
history of a seizure disorder and has remained seizure free since 2009.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Bailey receiving an exemption.
Thomas A. DeAngelo
Mr. DeAngelo is a 43 year-old class A CDL holder in Illinois. He
has a history of a seizure disorder and has remained seizure free since
1990. He takes anti-seizure medication with the dosage and frequency
remaining the same since 1998. His physician states that he is
supportive of Mr. DeAngelo receiving an exemption.
Nathan Dermer
Mr. Dermer is a 40 year-old driver in Alaska. He has a history of a
benign brain tumor removal in 1991 and a single seizure in 1994. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. His physician states that he is supportive of
Mr. Dermer receiving an exemption.
Daniel Lloyd Halstead
Mr. Halstead is a 63 year-old class A CDL holder in Nevada. He has
a history of a seizure disorder and has remained seizure free since
1973. He takes anti-seizure medication with the dosage and frequency
remaining the same since 2005. His physician states that he is
supportive of Mr. Halstead receiving an exemption.
Kevin Mathis
Mr. Mathis is a 29 year-old driver in New Jersey. He has a history
of juvenile myoclonic epilepsy and has remained seizure free since
2003. He takes anti-seizure medication with the dosage and
[[Page 79399]]
frequency remaining the same since that time. His physician states that
he is supportive of Mr. Mathis receiving an exemption.
Toriano T. Mitchell
Mr. Mitchell is a 32 year-old class B CDL holder in Ohio. He has a
history of a seizure disorder and has remained seizure free since 2003.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Mitchell receiving an exemption.
Thomas A. Mitman
Mr. Mitman is a 58 year-old class A CDL holder in New York. He has
a history of a seizure disorder and has remained seizure free since
1996. He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Mitman receiving an exemption.
James P. Murphy
Mr. Murphy is a 39 year-old driver in Massachusetts. He has a
history of a single seizure and tumor removal in 2011. He was
previously on anti-seizure medication but discontinued it 2015. His
physician states that he is supportive of Mr. Murphy receiving an
exemption.
Jason Christopher Nikolas
Mr. Nikolas is a 42 year-old driver in Virginia. He has a history
of epilepsy and has remained seizure free since 2012. He takes anti-
seizure medication with the dosage and frequency remaining the same
since that time. His physician states that he is supportive of Mr.
Nikolas receiving an exemption.
Curtis Joseph Palubicki
Mr. Palubicki is a 29 year-old driver in Minnesota. He has a
history of epilepsy and has remained seizure free since September 2008.
He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Palubicki receiving an exemption.
Franklin Prettyman
Mr. Prettyman is a 77 year-old driver in Maryland. He has a history
of a seizure disorder and has remained seizure free since 2012. He
takes anti-seizure medication with the dosage and frequency remaining
the same since that time. His physician states that he is supportive of
Mr. Prettyman receiving an exemption.
Chad Riemenschneider
Mr. Riemenschneider is a 35 year-old driver in Texas. He has a
history of a single seizure in 2011 related to a brain tumor. He takes
anti-seizure medication with the dosage and frequency remaining the
same since that time. His physician states that he is supportive of Mr.
Riemenschneider receiving an exemption.
Isaac E. Rogers
Mr. Rogers is a 29 year-old class A CDL holder in Illinois. He has
a history of a seizure disorder and has remained seizure free since
2009. He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Rogers receiving an exemption.
Tyler W. Schaefor
Mr. Schaefor is a 34 year-old driver in Maine. He has a history of
a seizure disorder and has remained seizure free since 2003. He takes
anti-seizure medication with the dosage and frequency remaining the
same since 2008. His physician states that he is supportive of Mr.
Schaefor receiving an exemption.
Kenneth P. Schmitt
Mr. Schmitt is a 38 year-old driver in South Dakota. He has a
history of a seizure disorder and his last seizure date is not
documented. He takes anti-seizure medication with the dosage and
frequency remaining the same and his physician notes that Mr. Schmitt
admits to occasional anti-seizure medication noncompliance. His
physician states that he is supportive of Mr. Schmittt receiving an
exemption.
Alfonso Valdivieso
Mr. Valdivieso is a 52 year-old class A CDL holder in New York. He
has a history of a seizure disorder and has remained seizure free since
2011. He takes anti-seizure medication with the dosage and frequency
remaining the same since that time. His physician states that he is
supportive of Mr. Valdivieso receiving an exemption.
Request for Comments
In accordance with 49 U.S.C. 31315 and 31136(e), FMCSA requests
public comment from all interested persons on the exemption
applications described in this notice. We will consider all comments
received before the close of business on the closing date indicated
earlier in the notice.
Dated: December 9, 2015.
Larry W. Minor,
Associate Administrator for Policy.
[FR Doc. 2015-31978 Filed 12-18-15; 8:45 am]
BILLING CODE 4910-EX-P